…TIMESLOT: Thursday 08 January 2026, 16:00 CET
…MAIN TITLE: Challenges in the diagnosis and treatment of inherited neuropathies
…PRESENTERS: Dr. Davide Pareyson (Fondazione IRCCS Istituto Neurologico C.Besta (FINCB), Milan, Italy) & Dr. Filippo Genovese (The European Charcot-Marie-Tooth Federation & ACMT-Rete per la malattia di Charcot-Marie-Tooth OdV)
Davide Pareyson, MD, is a Clinical Neurologist working at the Fondazione IRCCS Istituto Neurologico C.Besta (FINCB) of Milan, Italy, where he is Head of the Functional Department of Rare Neurological Diseases and Chief of the Simple Dept. Unit of “Rare Neurological Diseases of Adulthood”. He graduated in Medicine at the Milan University and has a Board in Neurology and in Clinical Neurophysiology. His main interest is clinical research on hereditary and acquired peripheral neuropathies and motor neuronopathies, inherited neurological disorders, rare diseases. He performed studies on phenotype-genotype correlation, clinical findings, electrophysiology, neuropathology of hereditary neuropathies (particularly Charcot-Marie-Tooth disease – CMT – and related neuropathies, but also amyloid neuropathy) and other neurogenetic disorders including spinal and bulbar muscle atrophy, hereditary spastic paraplegias, hereditary ataxias, genetic leukodystrophies. He has been working on the development of outcome measures for hereditary neuropathies and other rare diseases and has coordinated and participated in clinical trials and natural history studies in inherited and acquired neuropathies. He is the Coordinator of the National Registries of Charcot-Marie-Tooth disease and of Spino-Bulbar Muscular Atrophy.
Filippo Genovese is the President of the European CMT Federation and Chief Scientific Officer of ACMT-Rete per la malattia di Charcot-Marie-Tooth OdV, an Italian PAG of CMT patients and a founder member of the Federation. He has a scientific background (Ph.D. in Pharmaceutical Sciences, working in the field of Mass Spectrometry/Proteomics) and he lends a hand to both ACMT-Rete and ECMTF with informatics too (website, social media, communication). He suffers from Charcot-Marie-Tooth 1X, but he does not live the relationship with the disease as a condemnation but as a part of him. It was not easy to metabolize it and it is not easy at certain times when the difficulties related to the disease add up to everything else. He tries to convey this energy and turn it into a stimulus to advocate for a better quality of life for people with a neuromuscular condition.